Your browser doesn't support javascript.
loading
First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer.
Digklia, Antonia; Boughdad, Sarah; Homicsko, Krisztian; Dromain, Clarisse; Trimech, Mounir; Dolcan, Ana; Peters, Solange; Prior, John; Schaefer, Niklaus.
Afiliação
  • Digklia A; Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland antonia.digklia@chuv.ch.
  • Boughdad S; Sarcoma Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Homicsko K; University of Lausanne, Lausanne, Switzerland.
  • Dromain C; Nuclear Medicine and Molecular Imaging, University of Lausanne, Lausanne, Switzerland.
  • Trimech M; Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Dolcan A; University of Lausanne, Lausanne, Switzerland.
  • Peters S; Precision Oncology Center, Lausanne University Hospital, Lausanne, Switzerland.
  • Prior J; University of Lausanne, Lausanne, Switzerland.
  • Schaefer N; Radiology and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland.
J Immunother Cancer ; 10(10)2022 Oct.
Article em En | MEDLINE | ID: mdl-36288828
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Lutécio Limite: Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Lutécio Limite: Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça